PENTHRANE
LOE ApproachingNDAINHALATIONLIQUIDPriority Review
Approved
May 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 55m ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PENTHRANE (methoxyflurane) is an inhalational volatile anesthetic liquid approved in 1962 for general anesthesia. It is a small-molecule halogenated ether administered via inhalation for surgical anesthesia induction and maintenance. The drug works by depressing the central nervous system through enhancement of inhibitory neurotransmission.
LOE Approaching
This product is in late lifecycle with minimal linked job opportunities, suggesting a small or legacy team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PENTHRANE offers minimal commercial or medical career growth opportunities given its late-lifecycle status and zero linked job openings. This is a product managed for continuity and compliance rather than revenue expansion or innovation.
Manufacturing ManagerRegulatory Affairs Specialist
Worked on PENTHRANE at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.